Vermont Hospital Filings Use Real Numbers. The Baselines Can Still Tell Very Different Stories.

Part 1 explained why Vermont's hospital budget process matters. Part 2 examined UVM Health's systemwide finances, Medical Group losses and commercial-rate arguments. Part 3 looks at how individual hospital presentations frame their requests.

Hospital budget presentations rarely depend on invented numbers.

They depend on which number is compared with which.

Central Vermont Medical Center, Porter Hospital and Rutland Regional Medical Center all disclose weaknesses in their fiscal year 2027 filings.

They also show how budget-to-budget, projection-to-budget and actual-to-budget comparisons can make the same financial condition appear very different.

CVMC is candid — but the baseline moves

Central Vermont Medical Center's FY2027 presentation is among the more forthcoming.

CVMC projects a $10.6 million fiscal 2026 operating loss, reports weak productivity in several departments and says no service lines will be closed, transferred, reduced or added.

It also meets the Board's commercial benchmarks, proposing a 1% commercial rate reduction and a 1% reduction in commercial net patient revenue.

Expenses are less straightforward.

CVMC reports 8.6% budget-to-budget expense growth against the Board's 2.4% guidance.

Yet several slides earlier, while describing improvement from its current position, CVMC says expenses rise just $3.3 million to $344.7 million — roughly 1% compared with its current fiscal 2026 projection.

Both figures can be correct.

They answer different questions.

The baseline changes depending on whether CVMC is explaining why it exceeds the benchmark or why its financial outlook is improving.

A similar issue appears in the headline "The Budgeted Loss Narrows to $3.3M."

A footnote adds approximately $1.1 million for a commercial revenue enforcement order issued July 8, putting the adjusted budgeted loss closer to $4.4 million.

The larger number is disclosed.

The smaller one gets the headline.

Porter's recovery depends heavily on things it identifies as risks

Porter Hospital's FY2027 presentation acknowledges a substantial fiscal 2026 miss.

Porter projects approximately $2.1 million in operating margin against a $10.1 million budget, with revenue about $9 million below plan due partly to operating-room and inpatient volume, Act 55 and 340B pharmacy revenue.

For fiscal 2027, Porter budgets approximately $12 million in operating margin.

Its bridge to that improvement includes $4.6 million from surgical volume and case mix, $2.5 million from Lab, MRI, CT and emergency-department run rates, $2 million from Medicare inflation, and $2.1 million from Infusion Expense Stabilization, offset by $1.2 million of continued 340B erosion.

Porter itself identifies "OR volume materializing" and maintaining current infusion services as risks.

Those two items account for $6.7 million of the roughly $10 million improvement the hospital is attempting to achieve.

The baseline makes the growth assumptions look smaller.

Porter compares fiscal 2027 volume largely against its fiscal 2026 budget — a budget it did not meet.

Against fiscal 2025 actuals, operating-room cases rise roughly 16.6%. GI and endoscopy rises about 34.5%.

The starkest example is inpatient days.

Porter presents them as essentially flat, down 0.2% budget-to-budget.

Compared with fiscal 2025 actuals, fiscal 2027 inpatient days are approximately 21% higher.

The sign flips depending on the baseline.

"Vermonters will not pay more" needs a qualifier

Porter's presentation states:

"Vermonters will not pay more for care at Porter Hospital in FY27."

The narrower claim is defensible.

Porter proposes a 0% commercial reimbursement-rate increase and a 1% reduction in gross charges.

But total net patient service revenue is budgeted to rise approximately 10.4%, from roughly $126.4 million to $139.5 million, through volume and case-mix changes.

Holding unit prices flat is not the same as holding total spending flat.

Porter's commercial-rate slide contains another ambiguity.

Three displayed adjustments reconcile to the stated $3.09 million total only if the $125,000 radiology billing change is treated as a positive adjustment rather than another reduction. The slide formats the items similarly and does not explain the distinction.

RRMC is unusually candid about a budget already getting worse

Rutland Regional Medical Center's hearing is scheduled for Friday, August 7. This analysis is based on its filed FY2027 presentation; testimony during the hearing may provide additional explanation.

RRMC budgets an $8.7 million operating loss, or negative 2.3%.

It then tells the Board that the budget is already stale.

Its "Illustrative Revised Outlook" puts the loss at approximately $15.1 million, or negative 4.1%, following an ophthalmology departure, unexpected physician retirements and the end of Medicaid's hospital global-budget program.

That disclosure is unusually candid.

It is not the only point in RRMC's favor.

The hospital proposes a 0% charge-master increase, expands free-care eligibility from 300% to 400% of the federal poverty level, reports employee turnover falling for four consecutive years to 14.5% against an 18% national benchmark, and says its CMS star rating improved from one star to three.

RRMC also proposes a 2.6% commercial rate reduction, comfortably beating the Board's requested 1% reduction.

Its other commercial benchmark tells a different story.

RRMC meets one commercial benchmark and misses another

Commercial net patient revenue is separate from the commercial reimbursement rate.

There RRMC does not meet the Board's guidance.

Commercial net patient revenue is budgeted to rise 0.8% against guidance calling for a 1% reduction — a 1.8 percentage-point miss.

RRMC's summary slides emphasize that the budget complies with the benchmark on commercial rates.

The commercial net patient revenue miss appears deeper in the presentation, alongside a two-year comparison producing a more favorable result.

Both numbers are real.

Only one gets emphasized.

RRMC wants roughly $16 million treated differently

RRMC reports approximately 6.9% budget-to-budget expense growth, or $24.7 million.

It then asks the Board to remove major portions from the benchmark calculation.

One request involves approximately $11.1 million in retail and specialty pharmacy expenses.

A separate slide proposes a $5.1 million 340B accounting change, which would net drug acquisition costs against revenue in a manner RRMC says would resemble reporting used by critical-access hospitals.

RRMC is not a critical-access hospital.

Combined, the requests involve about $16.2 million, or more than five percentage points of the hospital's reported 6.9% expense growth.

The Board may conclude that some or all of those adjustments are justified.

They should still be viewed together.

The pharmacy bet already missed once

RRMC budgets approximately $37.3 million in combined 340B and retail-pharmacy revenue.

Retail-pharmacy revenue alone is projected to rise roughly 54% over the current fiscal 2026 projection.

At the same time, RRMC identifies 340B eligibility and possible manufacturer changes among its major financial risks.

More importantly, fiscal 2026 pharmacy gross revenue is already running approximately $13.4 million below budget — the largest revenue variance in the filing.

That does not make the fiscal 2027 forecast impossible.

It means the hospital is budgeting substantial growth in a business line that has already materially missed expectations and that management itself identifies as vulnerable.

That assumption deserves testing at the hearing.

Accurate does not mean impartial

None of these examples requires accusing a hospital of falsifying a number.

The numbers are generally there.

The question is which one gets the headline.

CVMC can describe 8.6% expense growth and roughly 1% expense growth depending on the baseline.

Porter can show inpatient days falling 0.2% while another valid comparison shows them rising about 21%.

RRMC can correctly say it beats the commercial rate benchmark while missing the separate commercial net patient revenue benchmark.

Those are not necessarily contradictions.

They are choices about how to present the same underlying financial condition.

The Green Mountain Care Board's job is not merely to confirm that every percentage can be reproduced with a calculator.

It has to decide whether the assumptions are realistic, whether requested exclusions are justified, and whether the comparisons hospitals choose give Vermonters a fair picture of what the budget will actually cost.

The figures are evidence.

The framing is part of the case.